Structured Self-Monitoring of Blood Glucose Regimens Improve Glycemic Control in Poorly Controlled Chinese Patients on Insulin Therapy: Results from COMPASS.

Linong Ji,Qing Su,Bo Feng,Zhongyan Shan,Renming Hu,Xiaoping Xing,Yaoming Xue,Tao Yang,Yanyin Hua
DOI: https://doi.org/10.1111/1753-0407.12434
IF: 4.53
2016-01-01
Journal of Diabetes
Abstract:BackgroundThe use of self-monitoring of blood glucose (SMBG) among patients with insulin-treated, type 2 diabetes (T2DM) in China is suboptimal. Herein we evaluated the effectiveness of structured SMBG for improving glycemic control and increasing the frequency of SMBG.MethodsInsulin-treated (>3months) T2DM patients aged 18years with HbA1c >8.0% (64mmol/mol) were recruited to the study. They received SMBG materials and were advised on a structured SMBG regimen for their insulin therapy. Patients were trained to self-adjust insulin dosage according to SMBG readings and were seen by physicians at Months 3 and 6. Endpoints included changes in HbA1c, SMBG frequency, and hypoglycemia frequency.ResultsThe study enrolled 820 patients, with mean ( SD) age 55.19.8years, body mass index 24.93.6kg/m(2), HbA1c 9.71.6% (83mmol/mol), and diabetes duration 9.87.1years, with median insulin therapy of 30.3 (3.0-274.1) months, from 19 Chinese clinics. By Month 3, 99.9% of patients performed daily SMBG. At Months 3 and 6, HbA1c had decreased from baseline (-1.81% and -1.73%, respective; P<0.0001 for both), with reduced hypoglycemia. In addition, 36.2% and 39.9% of patients achieved HbA1c <7.0% (53mmol/mol) at Months 3 and 6, respectively. The largest HbA1c improvements were for patients with a shorter duration of diabetes and insulin therapy.ConclusionsA structured SMBG regimen, with training on interpretation of and responses to SMBG readings, increased SMBG frequency and improved HbA1c and the management of insulin-treated T2DM.
What problem does this paper attempt to address?